Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Total 13F shares
-
36,371,724
-
Share change
-
+4,481,461
-
Total reported value
-
$2,613,474,662
-
Put/Call ratio
-
57%
-
Price per share
-
$71.86
-
Number of holders
-
227
-
Value change
-
+$329,094,500
-
Number of buys
-
136
-
Number of sells
-
67
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q2 2023
As of 30 Jun 2023,
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) was held by
227 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,371,724 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, VANGUARD GROUP INC, BlackRock Inc., Fairmount Funds Management LLC, BVF INC/IL, FMR LLC, RA CAPITAL MANAGEMENT, L.P., STATE STREET CORP, ALETHEA CAPITAL MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
227
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.